RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
8.81
-0.13 (-1.45%)
Feb 25, 2026, 4:00 PM EST - Market closed
RxSight Market Cap
RxSight has a market cap or net worth of $362.24 million as of February 26, 2026. Its market cap has decreased by -71.97% in one year.
Market Cap
362.24M
Enterprise Value
145.15M
1-Year Change
-71.97%
Ranking
Category
Stock Price
$8.81
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has decreased from $424.33M to $362.24M, a decrease of -14.63%. That is a compound annual growth rate of -3.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 362.24M | -15.45% |
| Dec 31, 2025 | 428.44M | -69.08% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
| Jul 30, 2021 | 424.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cerus | 464.85M |
| ClearPoint Neuro | 450.98M |
| Standard BioTools | 449.94M |
| OrthoPediatrics | 419.29M |
| Delcath Systems | 354.29M |
| Senseonics Holdings | 339.53M |
| Viemed Healthcare | 327.33M |
| Owlet | 325.18M |